How it worksTechnologyClinical dataProductsCompanyGet updates

Photothermal detection

Our method detects how mid-infrared light interacts with glucose molecules in the skin. It builds on well researched spectroscopy, developed further over 15 years at Goethe University Frankfurt.

Inside the D-Pocket

Select a part to see where it sits on the optical bench.

The D-Pocket held in a hand

Clinical data

DiaMonTech's latest clinical study shows that the non-invasive system can reach medical-grade accuracy, comparable to early invasive CGM devices approved by the FDA and EU notified bodies.

20.7 %MARD
19.6 %MARD

MARD is the mean absolute relative difference between a device and a reference measurement. Lower is better. We keep refining the system for even greater accuracy and reliability.

Error grid plot: non-invasive glucose readings against a blood glucometer, most points inside zones A and B
Error grid published by DiaMonTech: non-invasive readings (vertical) against a reference blood glucometer (horizontal).
D-Sensor integrated in a smartwatch

D-Sensor for wearables

Together with partners we are developing a miniaturised version of the same mid-infrared technology, small enough to be integrated into future wearables for anyone who wants to keep an eye on their glucose.

Diamoki, the companion app

A diabetes diary for glucose, blood pressure, food, activity, weight and medication, with data imported from health apps or your meter.

Questions about the D-Pocket

When can I buy the D-Pocket?

The D-Pocket is still in development. Clinical studies and certification follow, so there is no launch date yet. Newsletter subscribers hear first.

Where will it be available?

It will first be marketed in European countries and the USA. There is no waiting list, but investors will have priority access to the first devices.

Can I test the technology?

Not yet. The technology is tested internally and in clinical studies. When we look for testers, we will announce it here and in the newsletter.

Will health insurance cover it?

We are in contact with health insurance companies and are confident the costs will be covered.

What makes the method different?

Short mid-infrared pulses are absorbed by glucose in the tissue fluid and create small heat waves, detected with our patented IRE-PTD method. This keeps the measurement selective for glucose.

Be the first to hear when the D‑Pocket is ready

People with diabetes

Development news, study results and launch dates, a few times a year.

Investors

Securities information, general meeting and IPO questions.

ir@diamontech.de

Press

Images, interviews and background on the technology.

news@diamontech.de